Pourtau, L.; Wauquier, F.; Boutin-Wittrant, L.; Gaudout, D.; Moras, B.; Vignault, A.; Vaysse, C.; Richard, T.; Courtois, A.; Krisa, S.;
et al. Reduced Production of Pro-Inflammatory and Pro-Catabolic Factors by Human Serum Metabolites Derived from a Patented Saffron Extract Intake. Pharmaceutics 2024, 16, 336.
https://doi.org/10.3390/pharmaceutics16030336
AMA Style
Pourtau L, Wauquier F, Boutin-Wittrant L, Gaudout D, Moras B, Vignault A, Vaysse C, Richard T, Courtois A, Krisa S,
et al. Reduced Production of Pro-Inflammatory and Pro-Catabolic Factors by Human Serum Metabolites Derived from a Patented Saffron Extract Intake. Pharmaceutics. 2024; 16(3):336.
https://doi.org/10.3390/pharmaceutics16030336
Chicago/Turabian Style
Pourtau, Line, Fabien Wauquier, Line Boutin-Wittrant, David Gaudout, Benjamin Moras, Adeline Vignault, Carole Vaysse, Tristan Richard, Arnaud Courtois, Stéphanie Krisa,
and et al. 2024. "Reduced Production of Pro-Inflammatory and Pro-Catabolic Factors by Human Serum Metabolites Derived from a Patented Saffron Extract Intake" Pharmaceutics 16, no. 3: 336.
https://doi.org/10.3390/pharmaceutics16030336
APA Style
Pourtau, L., Wauquier, F., Boutin-Wittrant, L., Gaudout, D., Moras, B., Vignault, A., Vaysse, C., Richard, T., Courtois, A., Krisa, S., Roux, V., Macian, N., Pickering, G., & Wittrant, Y.
(2024). Reduced Production of Pro-Inflammatory and Pro-Catabolic Factors by Human Serum Metabolites Derived from a Patented Saffron Extract Intake. Pharmaceutics, 16(3), 336.
https://doi.org/10.3390/pharmaceutics16030336
